Plant-Derived Anticancer Drugs in the OMICS Era

Plant-Derived Anticancer Drugs in the OMICS Era Biosynthesis, Function, and Applications

Hardback (27 Oct 2023)

  • $196.85
Add to basket

Includes delivery to the United States

10+ copies available online - Usually dispatched within 7-10 days

Publisher's Synopsis

The current anti-cancer synthetic medicines are deemed inefficient and unsafe, state the editors of this new book. Plant-based lead molecules, however, such as taxol, camptothecin, podophyllotoxins, vinblastine, vincristine, homoharringtonine, and numerous other anticancer compounds from nature's arsenal, are potentially safe and can be powerful alternatives that effectively fight against cancer.

The volume looks at a variety of medicinal plants and approaches that have shown beneficial results against cancer. Topics in the book include Unani approaches of anticancer plants, genetic engineering and CRISPR/CAS-mediated editing to enhance a plant's anticancer potential, computational approaches used in anticancer plants, and more. The volume also examines the metabolomics of plants that give them anti-cancer properties.

Book information

ISBN: 9781774912652
Publisher: CRC Press
Imprint: Apple Academic Press
Pub date:
DEWEY: 615.798
DEWEY edition: 23
Language: English
Number of pages: 311
Weight: 652g
Height: 158mm
Width: 236mm
Spine width: 24mm